Quarterly report pursuant to Section 13 or 15(d)

Note 7 - Supplemental Equity and Accumulated Other Comprehensive Income (Loss)

Note 7 - Supplemental Equity and Accumulated Other Comprehensive Income (Loss)

9 Months Ended

Mar. 31, 2019

Notes to Financial Statements

Comprehensive Income (Loss) Note [Text Block]

Note

Supplemental Equity and Accumulated Other Comprehensive Income (loss):

Consolidated Changes in Equity (amounts in thousands)

	Common Stock						Additional Paid-in		Retained			Accumulated Other Comprehensive
	Shares			Amount			Capital		Earnings			Income(Loss)			Total
Balances at June 30, 2018		37,608		$	376		$	246,568	$	876,931		$	(44,814	)	$	1,079,061
Cumulative effect adjustments due to adoption of new accounting standards										24,780			(24,682	)		98
Net earnings										17,403						17,403
Other comprehensive loss													(1,136	)		(1,136	)
Share repurchases																-
Surrender and retirement of stock to exercise options																-
Common stock issued for exercise of options		166			2			15,609								15,611
Common stock issued for restricted stock awards		24			0					(1,909	)					(1,909	)
Cash dividends										(12,066	)					(12,066	)
Stock-based compensation expense								11,327								11,327
Common stock issued to employee stock purchase plan		5			0			842								842
Employee stock purchase plan expense								238								238
Balances at September 30, 2018		37,803		$	378		$	274,584	$	905,139		$	(70,632	)	$	1,109,469
Net earnings										17,556						17,556
Other comprehensive loss													(12,379	)		(12,379	)
Share repurchases		(95	)		(1	)				(15,404	)					(15,404	)
Surrender and retirement of stock to exercise options																-
Common stock issued for exercise of options		24			0			2,408								2,408
Common stock issued for restricted stock awards		3			0					0						-
Cash dividends										(12,086	)					(12,086	)
Stock-based compensation expense								6,784								6,784
Common stock issued to employee stock purchase plan		0			0											-
Employee stock purchase plan expense								77								77
Balances at December 31, 2018		37,735		$	377		$	283,854	$	895,205		$	(83,011	)	$	1,096,425
Net earnings										44,654						44,654
Other comprehensive income													3,378			3,378
Share repurchases																-
Surrender and retirement of stock to Exercise options																-
Common stock issued for exercise of Options		73			1			7,336								7,337
Common stock issued for restricted stock Awards		1			0											-
Cash dividends										(12,086	)					(12,086	)
Stock-based compensation expense								5,640								5,640
Common stock issued to employee stock Purchase plan		4			0			834								834
Employee stock purchase plan expense								84								84
Balances at March 31, 2019		37,813		$	378		$	297,748	$	927,773		$	(79,633	)	$	1,146,266

	Common Stock				Additional Paid-in		Retained			Accumulated Other Comprehensive
	Shares		Amount		Capital		Earnings			Income(Loss)			Total
Balances at June 30, 2017		37,356	$	374	$	199,161	$	799,027		$	(48,935	)	$	949,627
Net earnings								15,863						15,863
Other comprehensive loss											(824	)		(824	)
Surrender and retirement of stock to exercise options														0
Common stock issued for exercise of options		33		0		3,051								3,051
Common stock issued for restricted stock awards		13		0				(227	)					(227	)
Cash dividends								(11,958	)					(11,958	)
Stock-based compensation expense						3,718								3,718
Common stock issued to employee stock purchase plan		7		0		755								755
Employee stock purchase plan expense						77								77
Balances at September 30, 2017		37,409	$	374	$	206,762	$	802,705		$	(49,759	)	$	960,082
Net earnings								48,847						48,847
Other comprehensive loss											(7,058	)		(7,058	)
Surrender and retirement of stock to exercise options														-
Common stock issued for exercise of options		38		1		2,892								2,893
Common stock issued for restricted stock awards		22		0				0						-
Cash dividends								(11,988	)					(11,988	)
Stock-based compensation expense						4,985								4,985
Common stock issued to employee stock purchase plan		-				-								-
Employee stock purchase plan expense						59								59
Balances at December 31, 2017		37,470	$	375	$	214,697	$	839,564		$	(56,817	)	$	997,819
Net earnings								19,738						19,738
Other Comprehensive Loss											40,956			40,956
Surrender and retirement of stock to Exercise options														-
Common stock issued for exercise of options		68				6,273								6,273
Common Stock issued for restricted stock awards														-
Cash dividends								(11,992	)					(11,992	)
Stock-based compensation expenses						4,669								4,669
Common stock issued to employee stock purchase plan		7				752								752
Employee stock purchase plan expense						78								78
Balances at March 31, 2018		37,545	$	375	$	226,469	$	847,310		$	(15,862	)	$	1,058,292

Accumulated Other Comprehensive Income

The components of other comprehensive income (loss) consist of changes in net unrealized gains (losses) on available for sale investments with readily determinable fair values in fiscal

2018,

changes in foreign currency translation adjustments, and changes in net unrealized gains (losses) on derivative instruments designated as cash flow hedges entered into in fiscal

2019.

There were

reclassifications of gains (losses) from accumulated other comprehensive income (loss) to earnings during the

nine

months ended

March 31, 2019

and

2018.

The accumulated balances related to each component of other comprehensive income (loss), net of tax, are summarized as follows (in thousands):

	Unrealized
	Gains						Unrealized
	(Losses) on			Foreign			Gains
	Available-			Currency			(Losses) on
	for-Sale			Translation			Derivatives
	Investments			Adjustments			Instruments			Total
Beginning balance as of June 30, 2018	$	24,682		$	(69,496	)	$	-		$	(44,814	)
Cumulative effect adjustment for adoption for ASU 2018-02 (1)		2,371			-			-			2,371
Cumulative effect adjustment for adoption for ASU 2016-01 (1)		(27,053	)		-			-			(27,053	)
Other comprehensive income (loss), net of tax benefit of $1,792 on derivative instruments (2)		-			(4,368	)		(5,769	)		(10,137	)
Ending balance as of March 31, 2019	$	-		$	(73,864	)	$	(5,769	)	$	(79,633	)

(

)

See Note

for further information related to the adoption of ASU

2016

and

2018

02.

(

)

The gain (loss) on the forward starting interest rate swap will be reclassified into earnings beginning

October 31, 2019.

Approximately (

$919

) of the (

$5,769

) will be reclassified into earnings in the

months subsequent to

March

31,

2019.

	Unrealized
	Gains					Unrealized
	(Losses) on		Foreign			Gains
	Available-		Currency			(Losses) on
	for-Sale		Translation			Derivative
	Investments		Adjustments			Instruments		Total
Beginning balance as of June 30, 2017	$	18,989	$	(67,924	)	$	-	$	(48,935	)
Other comprehensive income (loss)		22,286		10,787			-		33,073
Ending balance as of March 31, 2018	$	41,275		(57,137	)	$	-	$	(15,862	)